| Application no. and date | 19896475.1 (espacenet) (Federated) (European Patent Register), 20191212 | | Patent/reg. no. and date | DK/EP 3893889, 20260128 | | Publication date | 20211020 | | Priority no. and date | CN 201811527414, 20181213 | | EP pub. no. and date |
EP 3893889 20211020 | | Effective date | | | Applicant/owner | Terns Pharmaceuticals, Inc., 1065 East Hillsdale Blvd.
Suite 100
Foster City, California 94404, US | | Applicant ref. no. | V503031DK00 | | Inventor | YU, Shanghai, 1065 E. Hillsdale Blvd, Suite 100
Foster City, California 94404, US,
LI, Ben, 1065 E. Hillsdale Blvd, Suite 100
Foster City, California 94404, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/662 (2006.01) , A61P 1/16 (2006.01) , A61P 3/00 (2006.01) , A61P 3/04 (2006.01) , A61P 3/06 (2006.01) , A61P 3/10 (2006.01) , A61P 35/00 (2006.01) , A61P 5/14 (2006.01) , A61P 9/10 (2006.01) , C07D 403/12 (2006.01) , C07F 9/30 (2006.01) | | Title | THRB-RECEPTORAGONISTFORBINDELSE OG FREMGANGSMÅDE TIL FREMSTILLING OG ANVENDELSE DERAF | | Int. application no. | US2019066013 | | Int. publication no. | WO2020123827 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
